Between 2013 and 2023, the antidepressant medicine sales in Germany have displayed significant fluctuations. Starting at 791.7 million euros in 2013, the market experienced both growth and decline, peaking in 2014 with a value of 832.6 million euros. However, from 2015 to 2017, there was a notable downward trend, hitting a low of 702.5 million euros in 2017. The market then saw a gradual recovery, stabilizing around 714.0 million euros in 2021, and reaching 742.6 million euros in 2023, reflecting a 1.95% year-on-year growth and a 5-year CAGR of 0.71%.
Looking ahead, forecast data from 2024 to 2028 suggests a steady increase in antidepressant medicine sales. The market is expected to grow at an average annual rate of 1.41% over the next five years, culminating in a projected value of 811.6 million euros by 2028. This growth is aligned with the forecasted 7.26% 5-year growth rate.
Future trends to watch for include the impact of new pharmaceutical developments, changes in mental health policies, and awareness campaigns. Additionally, the ongoing effects of socio-economic factors on mental health conditions and their treatment will be crucial in shaping the market trajectory.
